Ondansetron Kabi (Ondansetron Hydrochloride Dihydrate)

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It helps prevent nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery in adult and pediatric patients.

GNH USA supplies Ondansetron Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Ondansetron Kabi acts on the serotonergic pathway that contributes to nausea and vomiting. It is indicated for: - Chemotherapy‑induced nausea and vomiting (CINV): Reduces the incidence and severity of CINV in adult and the adult and the adult and the … … … … … … … … … … … … … … … … … - Radiotherapy‑  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Post‑operative ...  ... ... ... ... ... ... ... "

Common